Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.350
+0.040 (3.05%)
At close: May 22, 2026, 4:00 PM EDT
1.352
+0.002 (0.15%)
After-hours: May 22, 2026, 7:01 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $50.82 million as of May 22, 2026. Its market cap has decreased by -14.49% in one year.
Market Cap
50.82M
Enterprise Value
-50.15M
1-Year Change
-14.49%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $50.82M, a decrease of -90.97%. That is a compound annual growth rate of -65.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 50.82M | -16.44% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 56.94M |
| Instil Bio | 55.48M |
| MiNK Therapeutics | 54.15M |
| Quantum BioPharma | 53.96M |
| Radiopharm Theranostics | 53.05M |
| Hyperion DeFi | 51.43M |
| Estrella Immunopharma | 49.92M |
| Xilio Therapeutics | 49.36M |